Status:
RECRUITING
Perspectives of Italian Employers Regarding the Return to Work Process of Employees Who Received a Cancer Diagnosis: a Qualitative Study
Lead Sponsor:
Azienda USL Reggio Emilia - IRCCS
Collaborating Sponsors:
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
Conditions:
Cancer Survivors
Eligibility:
All Genders
18+ years
Brief Summary
European Cancer Mission calls attention to the return to work (RTW) of cancer survivors (CSs), as one of the pivotal issues of the cancer continuum that need to be addressed through proper and prompt ...
Detailed Description
Data collection will be performed through individual semi-structured interviews. Each interview will last around 60 minutes, and it can be arranged in person or remotely, depending on the participant'...
Eligibility Criteria
Inclusion
- employers\* of a company
- being directly involved in managing the RTW process of at least one employee with cancer diagnosis in the last 5 years.
- An employer can be the specific person who represents the company where the employee was working at the time of cancer diagnosis or a person who supported the employee during the sickness absence and the RTW process (e.g., line manager, human resource manager).
Exclusion
- none
Key Trial Info
Start Date :
April 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06994182
Start Date
April 1 2025
End Date
February 1 2027
Last Update
August 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda USL IRCCS di Reggio Emilia
Reggio Emilia, RE, Italy, 42123